Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quentin M Anstee

Showing results (121-130 of 261) with videos related to

Pageof 27
Sort By:
Gut|March 23, 2016
Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver diseaseTimothy Hardy, Mujdat Zeybel, Christopher P Day, et al.
Journal of Hepatology|September 14, 2019
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in EuropeJeffrey V Lazarus, Mattias Ekstedt, Giulio Marchesini, et al.
JHEP Reports : Innovation in Hepatology|March 18, 2021
European 'NAFLD Preparedness Index' - Is Europe ready to meet the challenge of fatty liver disease?Jeffrey V Lazarus, Adam Palayew, Patrizia Carrieri, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 15, 2017
Effects of Exercise on Liver Fat and Metabolism in Alcohol DrinkersDavid Houghton, Kate Hallsworth, Christian Thoma, et al.
Gastroenterology|December 11, 2020
The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic SteatohepatitisZobair M Younossi, Quentin M Anstee, Vincent Wai-Sun Wong, et al.
Journal of Clinical Medicine|June 2, 2021
FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-AnalysisYasaman Vali, Jenny Lee, Jérôme Boursier, et al.
Hepatology Communications|September 27, 2023
Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver diseaseMorten A Karsdal, Kate Hallsworth, Jadine Scragg, et al.
Aging|October 17, 2016
Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humansWanqing Liu, Quentin M Anstee, Xiaoliang Wang, et al.
European Journal of Internal Medicine|January 21, 2022
Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosisChristian Labenz, Gerrit Toenges, Ming-Hua Zheng, et al.
Gastroenterology|January 29, 2019
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver DiseasePeter J Eddowes, Magali Sasso, Michael Allison, et al.
Pageof 27

Showing results (121-130 of 261) with videos related to

Sort By:
Pageof 27
Gut|March 23, 2016
Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver diseaseTimothy Hardy, Mujdat Zeybel, Christopher P Day, et al.
Journal of Hepatology|September 14, 2019
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in EuropeJeffrey V Lazarus, Mattias Ekstedt, Giulio Marchesini, et al.
JHEP Reports : Innovation in Hepatology|March 18, 2021
European 'NAFLD Preparedness Index' - Is Europe ready to meet the challenge of fatty liver disease?Jeffrey V Lazarus, Adam Palayew, Patrizia Carrieri, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 15, 2017
Effects of Exercise on Liver Fat and Metabolism in Alcohol DrinkersDavid Houghton, Kate Hallsworth, Christian Thoma, et al.
Gastroenterology|December 11, 2020
The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic SteatohepatitisZobair M Younossi, Quentin M Anstee, Vincent Wai-Sun Wong, et al.
Journal of Clinical Medicine|June 2, 2021
FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-AnalysisYasaman Vali, Jenny Lee, Jérôme Boursier, et al.
Hepatology Communications|September 27, 2023
Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver diseaseMorten A Karsdal, Kate Hallsworth, Jadine Scragg, et al.
Aging|October 17, 2016
Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humansWanqing Liu, Quentin M Anstee, Xiaoliang Wang, et al.
European Journal of Internal Medicine|January 21, 2022
Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosisChristian Labenz, Gerrit Toenges, Ming-Hua Zheng, et al.
Gastroenterology|January 29, 2019
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver DiseasePeter J Eddowes, Magali Sasso, Michael Allison, et al.
Pageof 27